Eldian Biomed is a pre-clinical proof-of-concept stage startup developing CloudLi, a novel disease-modifying therapy for osteoarthritis.
Eldian Biomed has raised €166k across 1 funding round from 1 investor, most recently a round in Mar 2026. Based in Bern, Switzerland; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-13 | Other |
| €166k |
| InnoBooster program |
| View deal → |
